Benzinga | Nov 2, 2020 04:04PM EST

Pacific Biosciences Q3 EPS $(0.14) Misses $(0.13) Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 26.32 percent increase over losses of $(0.19) per share from the same period last year.